Jemino, Baby Boy .
HRN: 22-13-31 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/26/2022
GENTAMICIN 40MG/ML, 2ML (AMP)
10/26/2022
11/02/2022
IV
15mg
Q24h
Potentially Septic Newborn (Thickly Msaf)
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes